uniQure files Form 144 for 33,000 RSUs vesting

uniQure NV submitted a Form 144 disclosing the proposed sale of 33,000 ordinary shares underlying restricted stock units that vest on 03/04/2026.

Rhea-AI Filing Summary

uniQure NV submitted a Form 144 disclosing the proposed sale of 33,000 ordinary shares underlying restricted stock units that vest on 03/04/2026. The filing also reports prior open-market sales by Matthew Kapusta of 12,378 shares on 02/25/2026 ($295,306.90) and 34,437 shares on 03/02/2026 ($342,586.16).

Insights

Insider Transactions Analyst

Form 144 lists vesting RSUs and recent insider sales by a named individual.

The filing shows 33,000 ordinary shares tied to restricted stock units vesting on 03/04/2026; it classifies the award as compensation. This identifies the securities intended for sale once transfer conditions permit.

Examples shown of prior dispositions include 12,378 and 34,437 shares sold on 02/25/2026 and 03/02/2026 with proceeds of $295,306.90 and $342,586.16. Cash‑flow treatment and any sale timing beyond the vesting date are not detailed in the excerpt.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does uniQure's Form 144 mean for the 33,000 RSUs (QURE)?

It notifies the SEC of the proposed sale of 33,000 ordinary shares underlying RSUs vesting on 03/04/2026. The filing classifies these units as compensation, indicating they become eligible for transfer upon vesting.

Who sold shares in the past three months for uniQure (QURE)?

Matthew Kapusta reported sales of 12,378 shares on 02/25/2026 and 34,437 shares on 03/02/2026, generating proceeds of $295,306.90 and $342,586.16, respectively.

Are the 33,000 shares already sold according to the Form 144 for QURE?

The filing lists the 33,000 shares as securities to be sold upon vesting on 03/04/2026. It reports them as proposed sales tied to vesting; the excerpt does not state whether the shares were actually sold.

What sale method is described for the shares in uniQure's Form 144?

The excerpt identifies the securities as vesting restricted stock units classified under compensation. Specific sale methods (block trades, broker transactions) and timing beyond the vesting date are not detailed in the provided content.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/04/2026 - 04:46 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001536290
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	uniQure N.V.
SEC File Number	001-36294
Address of Issuer	PAASHEUVELWEG 25A AMSTERDAM NETHERLANDS 1105 BP
Phone	1-339-970-7000
Name of Person for Whose Account the Securities are To Be Sold	Kapusta Matthew C
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
ORDINARY SHARES	CITIGROUP GLOBAL MARKETS 390 GREENWICH ST NEW YORK NY 10013	14581	132165.10	62291663	03/04/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
ORDINARY SHARES	03/04/2026	RESTRICTED STOCK UNITS VESTING	UNIQURE NV			33000	03/04/2026	COMPENSATION

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MATTHEW KAPUSTA PAASHEUVELWEG 25A AMSTERDAM P7 1105BP	ORDINARY SHARES	02/25/2026	12378	295306.90
MATTHEW KAPUSTA PAASHEUVELWEG 25A AMSTERDAM P7 1105BP	ORDINARY SHARES	03/02/2026	34437	342586.16

144: Remarks and Signature

Remarks	UNDER SECURITIES TO BE SOLD DATE ACQUIRED WAS VARIOUS DATES. THESE SELL TO COVER TRANSACTIONS WERE THE RESULT OF THE VESTING AND SETTLEMENT OF EQUITY AWARDS. THEY WERE NON DISCRETIONARY TRANSACTIONS
Date of Notice	03/04/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	CONFORMED SIGNATURE ON FILE
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)